| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $22.6M | $23.1M | $24.5M |
| YoY Revenue Growth % | -1.9% | -6.0% | — |
| Gross Profit | $17.3M | $17.4M | — |
| Gross Margin % | 76.5% | 75.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.9M | -$16.3M | -$2.7M |
| Operating Margin % | -8.3% | -70.8% | -11.2% |
| Net Income (GAAP) | $4.3M | -$10.8M | $766.0K |
| EBITDA (Normalized) | -$1.9M | -$16.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $558.0K | $3.2M | $3.1M |
| Capital Expenditures (CapEx) | $20.0K | $19.0K | — |
| Free Cash Flow (FCF) | $538.0K | $3.1M | $3.1M |
| FCF Margin % | 2.4% | 13.6% | 12.5% |
| Return on Invested Capital (ROIC %) | -5.1% | -39.0% | — |
| Cash & Short-Term Equivalents | $3.0M | $4.1M | — |
| Total Debt (Short + Long Term) | $1.7M | $11.9M | — |
| Total Stockholders' Equity | $30.3M | $25.2M | — |